• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Primary Immunodeficiencies: A Decade of Progress and a Promising Future.原发性免疫缺陷病：十年进展与光明未来。
Front Immunol. 2021 Feb 18;11:625753. doi: 10.3389/fimmu.2020.625753. eCollection 2020.
2
Unusual morphological abnormality of neutrophils in a patient with SARS-CoV-2 infection.一名感染新型冠状病毒肺炎（SARS-CoV-2）患者中性粒细胞的异常形态学改变
Br J Haematol. 2021 May;193(4):690. doi: 10.1111/bjh.17355. Epub 2021 Feb 17.
3
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.新冠疫情对以色列原发性免疫缺陷患者的临床影响较小。
Front Immunol. 2021 Jan 14;11:614086. doi: 10.3389/fimmu.2020.614086. eCollection 2020.
4
Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic.COVID-19 大流行期间原发性免疫缺陷病患者的临床管理。
Expert Rev Clin Immunol. 2021 Feb;17(2):163-168. doi: 10.1080/1744666X.2021.1873767. Epub 2021 Jan 15.
5
Interferon linked to COVID-19 severity.干扰素与新冠病毒疾病严重程度有关。
Nat Med. 2020 Dec;26(12):1806. doi: 10.1038/s41591-020-01164-x.
6
The Impact of the SARS-CoV-2 Pandemic in PID Patients Receiving Ig Replacement Therapy.2019冠状病毒病大流行对接受免疫球蛋白替代疗法的原发性免疫缺陷病患者的影响。
J Clin Immunol. 2021 May;41(4):733-737. doi: 10.1007/s10875-020-00958-5. Epub 2021 Jan 15.
7
Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?新冠疫情中的原发性免疫缺陷疾病：是易感因素还是保护因素？
Am J Med Sci. 2020 Dec;360(6):740-741. doi: 10.1016/j.amjms.2020.07.027. Epub 2020 Jul 29.
8
"The State of the Union": Current and Future Perspectives on Patient-Centric Care for Primary Immunodeficiencies and Immune Dysregulatory Diseases.《国情咨文》：原发性免疫缺陷和免疫调节异常疾病以患者为中心的照护之现状与未来展望
Front Immunol. 2019 Jul 26;10:1783. doi: 10.3389/fimmu.2019.01783. eCollection 2019.
9
Welcome to the 13th Volume of .欢迎来到第13卷。 （你提供的原文不完整，缺少具体书名等信息，我按照字面意思翻译了前面部分）
Immunotherapy. 2021 Jan;13(1):1-3. doi: 10.2217/imt-2020-0308. Epub 2020 Dec 7.
10
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.2020 年 4 月伊朗吉兰省 SARS-CoV-2 的血清流行率。
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.

引用本文的文献

1
Registry-Based Frequency and Clinical Characteristics of Inborn Errors of Immunity in Kazakhstan: A Retrospective Observational Cohort Study (2009-2023).哈萨克斯坦基于登记处的免疫缺陷病发病率及临床特征：一项回顾性观察队列研究（2009 - 2023年）
J Clin Med. 2025 Jul 29;14(15):5353. doi: 10.3390/jcm14155353.
2
Infection prevention in patients with inborn errors of immunity: Insights from Japan's nationwide study.免疫缺陷病患者的感染预防：来自日本全国性研究的见解。
Pediatr Int. 2025 Jan-Dec;67(1):e70093. doi: 10.1111/ped.70093.
3
A survey of diagnosis and therapy of inborn errors of immunity among practice-based physicians and clinic-based pneumologists and hemato-oncologists.针对基层医生、临床肺科医生和血液肿瘤学家开展的先天性免疫缺陷病诊断与治疗情况调查。
Front Immunol. 2025 Jun 5;16:1597635. doi: 10.3389/fimmu.2025.1597635. eCollection 2025.
4
Optimizing diagnostic and management pathways for patients with eosinophilia of unknown origin: a multidisciplinary protocol for urgent and non-urgent evaluation.优化不明原因嗜酸性粒细胞增多症患者的诊断和管理路径：紧急和非紧急评估的多学科方案
Front Med (Lausanne). 2025 Jun 4;12:1544047. doi: 10.3389/fmed.2025.1544047. eCollection 2025.
5
SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the Literature.SARS-CoV-2 变异株和特殊人群的临床结局：文献的范围综述。
Viruses. 2024 Jul 30;16(8):1222. doi: 10.3390/v16081222.
6
Charting a course for global progress in PIDs by 2030 - proceedings from the IPOPI global multi-stakeholders' summit (September 2023).绘制到 2030 年全球 PID 进展的路线图——来自 IPOPI 全球利益相关者峰会的会议记录（2023 年 9 月）。
Front Immunol. 2024 Jun 27;15:1430678. doi: 10.3389/fimmu.2024.1430678. eCollection 2024.
7
Paving the way in implementation of SCID newborn screening in developing nations: feasibility study and strategies to move forward in Malaysia.在发展中国家实施 SCID 新生儿筛查的探索之路：马来西亚的可行性研究及推进策略。
Front Immunol. 2024 Jun 25;15:1400247. doi: 10.3389/fimmu.2024.1400247. eCollection 2024.
8
Autosomal Recessive Hyper-IgE Syndrome in a Child With Beta Thalassemia Trait: A Case Report.一名患有β地中海贫血特征儿童的常染色体隐性高IgE综合征：病例报告
Cureus. 2024 Jun 6;16(6):e61864. doi: 10.7759/cureus.61864. eCollection 2024 Jun.
9
Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye.通过全外显子组测序对临床诊断为先天性免疫缺陷的患者进行遗传评估：来自土耳其专门的免疫缺陷研究中心的结果。
J Clin Immunol. 2024 Jul 2;44(7):157. doi: 10.1007/s10875-024-01759-w.
10
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity.提高免疫缺陷患者中针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）特异性免疫的策略概述
Vaccines (Basel). 2024 Jun 18;12(6):675. doi: 10.3390/vaccines12060675.

本文引用的文献

1
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.先天性免疫缺陷患者的 2019 年冠状病毒病：一项国际研究。
J Allergy Clin Immunol. 2021 Feb;147(2):520-531. doi: 10.1016/j.jaci.2020.09.010. Epub 2020 Sep 24.
2
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
3
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
4
Current Perspectives and Unmet Needs of Primary Immunodeficiency Care in Asia Pacific.亚太地区原发性免疫缺陷病护理的现状和未满足的需求。
Front Immunol. 2020 Aug 13;11:1605. doi: 10.3389/fimmu.2020.01605. eCollection 2020.
5
Hematopoietic Stem Cell Transplantation in Children with Inborn Errors of Immunity: a Multi-center Experience in Colombia.儿童先天性免疫缺陷疾病的造血干细胞移植：哥伦比亚多中心经验。
J Clin Immunol. 2020 Nov;40(8):1116-1123. doi: 10.1007/s10875-020-00856-w. Epub 2020 Sep 2.
6
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.全球努力定义 SARS-CoV-2 感染保护性免疫的人类遗传学。
Cell. 2020 Jun 11;181(6):1194-1199. doi: 10.1016/j.cell.2020.05.016. Epub 2020 May 13.
7
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations.血标本中检测到严重急性呼吸综合征冠状病毒 2 型 RNA。
Emerg Infect Dis. 2020 Jul;26(7):1631-1633. doi: 10.3201/eid2607.200839. Epub 2020 Jun 21.
8
Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.人类先天性免疫缺陷：2019 年国际免疫学会联合会表型分类更新。
J Clin Immunol. 2020 Jan;40(1):66-81. doi: 10.1007/s10875-020-00758-x. Epub 2020 Feb 11.
9
Editorial: Primary Immunodeficiencies Worldwide.社论：全球原发性免疫缺陷病
Front Immunol. 2020 Jan 22;10:3148. doi: 10.3389/fimmu.2019.03148. eCollection 2019.
10
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee.人类先天性免疫缺陷：国际免疫学联盟专家委员会 2019 年分类更新。
J Clin Immunol. 2020 Jan;40(1):24-64. doi: 10.1007/s10875-019-00737-x. Epub 2020 Jan 17.

Primary Immunodeficiencies: A Decade of Progress and a Promising Future.

作者信息

Meyts Isabelle, Bousfiha Aziz, Duff Carla, Singh Surjit, Lau Yu Lung, Condino-Neto Antonio, Bezrodnik Liliana, Ali Adli, Adeli Mehdi, Drabwell Jose

机构信息

Department of Pediatrics, Department of Microbiology, Immunology and Transplantation, Laboratory for Inborn Errors of Immunity, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

European Society for Immunodeficiencies (ESID), Amsterdam, Netherlands.

出版信息

Front Immunol. 2021 Feb 18;11:625753. doi: 10.3389/fimmu.2020.625753. eCollection 2020.

DOI:10.3389/fimmu.2020.625753
PMID:33679719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7935502/
Abstract
摘要